Neogen | NEOG - Equity Capital And Reserves


Neogen reported $2.09B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Cerus USD 64.22M 2.76M Dec/2025
Danaher USD 52.58B 368M Jun/2026
Idexx Laboratories USD 1.61B 56.47M Jun/2026
Illumina USD 2.84B 162M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Neogen USD 2.09B 9.5M Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Pacific Biosciences Of California USD 2.37M 2.98M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Utah Medical Products USD 120.37M 1.1M Mar/2026
Zoetis USD 3.23B 98M Mar/2026